Almac Group surpasses £1 billion revenue with accounts revealing record revenues, profit and employee numbers

Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced its highest ever revenue, profit and employee numbers. Figures released for Almac’s financial year ending 30 September 2024 reported £1.027 billion of revenues, a £69.5 million (7%) increase from 2023. Pre-tax profits rose by 27% to £119 million, up from £93.8 million in

Continue Reading

Almac Group announces £11m investment to expand global analytical services

The Almac Group has today announced an £11m investment and the creation of over 100 new jobs to expand its global analytical services capabilities. Over the past 18 months, Almac Sciences and Almac Pharma Services have jointly made this significant investment to expand their existing analytical laboratories, technology and resource to meet ongoing global demand.

Continue Reading

Almac Group announce record revenue figure with 1800 new roles created in global expansion programme

Almac Group, the global contract pharmaceutical development and manufacturing organisation, has today announced its financial results for year ending September 30, 2023. Figures released show the company recorded a £118 million (14%) rise in revenue, up from £840 million in 2022 to £958 million in the period.  Operating profit rose again – final pre-tax profits

Continue Reading